Bone fractures usually heal efficiently, but in some patients this process fails, causing nonunion. A recent study identifies ...

Vancouver, British Columbia — A highly controlled retrospective analysis suggests that denosumab (Prolia) leads to greater reduction in fracture risk than does zoledronic acid (Reclast) among ...

Author(s)Cummings SR, San Martin J, McClung MR, et al, FREEDOM Trial investigators. Denosumab for prevention of fractures in postmenopausal women with osteoporosis [published correction appears in N ...

Background: In the absence of head-to-head trials, indirect comparisons of randomized placebo-controlled trials may provide a viable option to assess relative efficacy. The purpose was to estimate the ...

Please provide your email address to receive an email when new articles are posted on . The anterior intrapelvic approach or modified Stoppa approach for the treatment of pelvic and acetabular ...

Please provide your email address to receive an email when new articles are posted on . Intra-articular calcaneus fractures are high-energy injuries that can result in significant functional loss and ...

Real World Evidence Study Showed use of Prolia Reduced Fracture Risk in Postmenopausal Women With Osteoporosis Versus Alendronate Treatment Longer Duration of Treatment With Prolia Was Associated With ...

These findings from nearly half a million patients provide evidence that Prolia is associated with greater fracture risk reduction than with alendronate," said Jeff Curtis, MD, MS, MPH, professor of ...